SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
06-Jun-24 7:57 PM View: | Cerus Corp (CERS) | 05-Jun-24 | Grant | 40,000 | $5.00 | $200,000.00 | 38% 105.07K to 145.07K | |
24-Apr-24 4:18 PM View: | Allogene Therapeutics, Inc. (ALLO) | 22-Apr-24 | Payment of Exercise | 17,360 | $3.47 | $60,188.90 | (6%) 282.82K to 265.46K | |
12-Mar-24 9:43 PM View: | BioLife Solutions, Inc. (BLFS) | 08-Mar-24 | Grant | 11,264 | -- | -- | 60% 18.63K to 29.9K | |
31-Jan-24 5:51 PM View: | Allogene Therapeutics, Inc. (ALLO) | 25-Jan-24 | Grant | 96,600 | -- | -- | 52% 186.22K to 282.82K | |
03-Nov-23 5:09 PM View: | BioLife Solutions, Inc. (BLFS) | 01-Nov-23 | Grant | 495 | -- | -- | 3% 18.14K to 18.63K | |
10-Oct-23 5:26 PM View: | BioLife Solutions, Inc. (BLFS) | 01-Oct-23 | Grant | 362 | -- | -- | 2% 17.78K to 18.14K | |
09-Jun-23 4:10 PM View: | Cerus Corp (CERS) | 07-Jun-23 | Grant | 40,000 | $5.00 | $200,000.00 | 61% 65.07K to 105.07K | |
26-Apr-23 5:20 PM View: | Allogene Therapeutics, Inc. (ALLO) | 24-Apr-23 | Grant | 186,219 | -- | -- | 100% 0 to 186.22K | |
18-Jan-23 7:01 PM View: | BioLife Solutions, Inc. (BLFS) | 03-Jan-23 | Grant | 10,187 | -- | -- | 134% 7.59K to 17.78K | |
06-Sep-22 8:00 PM View: | BioLife Solutions, Inc. (BLFS) | 01-Sep-22 | Grant | 7,589 | -- | -- | 100% 0 to 7.59K | |
03-Jun-22 5:12 PM View: | Cerus Corp (CERS) | 01-Jun-22 | Grant | 20,454 | -- | -- | 46% 44.62K to 65.07K | |
08-Sep-21 5:07 PM View: | Cerus Corp (CERS) | 05-Sep-21 | Option Exercise | 4,296 | -- | -- | 11% 40.32K to 44.62K | |
03-Jun-21 8:02 PM View: | Cerus Corp (CERS) | 02-Jun-21 | Grant | 14,888 | -- | -- | 59% 25.43K to 40.32K | |
03-Jun-21 8:02 PM View: | Cerus Corp (CERS) | 01-Jun-21 | Option Exercise | 13,228 | -- | -- | 108% 12.21K to 25.43K | |
08-Sep-20 5:57 PM View: | Cerus Corp (CERS) | 05-Sep-20 | Option Exercise | 4,296 | -- | -- | 54% 7.91K to 12.21K | |
13-Feb-20 5:54 PM View: | Cerus Corp (CERS) | 11-Feb-20 | Market Purchase | 3,614 | $4.75 | $17,165.10 | 84% 4.3K to 7.91K | 72% |
03-Feb-20 8:21 PM View: | Cerus Corp (CERS) | 29-Jan-20 | Market Purchase | 3,614 | $4.15 | $14,998.10 | 84% 4.3K to 7.91K | 97% |
10-Sep-19 3:01 PM View: | Cerus Corp (CERS) | 05-Sep-19 | Option Exercise | 4,297 | -- | -- | 100% 0 to 4.3K | |
05-Oct-17 8:17 PM View: | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition | 41,734 | -- | -- | (91%) 45.66K to 3.93K | |
05-Oct-17 8:17 PM View: | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition (change in control) | 3,927 | $180.00 | $706,860.00 | (100%) 3.93K to 0 | |
27-Sep-17 9:42 PM View: | Kite Pharma, Inc. (KITE) | 25-Sep-17 | Grant | 8,000 | -- | -- | 19% 41.89K to 49.89K | |
27-Sep-17 9:42 PM View: | Kite Pharma, Inc. (KITE) | 25-Sep-17 | Market Sale | 4,228 | $179.66 | $759,619.00 | (8%) 49.89K to 45.66K | (< 1%) |
04-Aug-17 7:50 PM View: | Kite Pharma, Inc. (KITE) | 03-Aug-17 | Option Exercise | 6,000 | $44.91 | $269,460.00 | 12% 49.4K to 55.4K | |
04-Aug-17 7:50 PM View: | Kite Pharma, Inc. (KITE) | 03-Aug-17 | Market Option Sale (Planned) | 6,000 | $110.06 | $660,343.00 | (11%) 55.4K to 49.4K | (63%) |
03-Aug-17 9:14 PM View: | Kite Pharma, Inc. (KITE) | 01-Aug-17 | Option Exercise | 3,000 | $44.91 | $134,730.00 | 5% 58.4K to 61.4K | |
03-Aug-17 9:14 PM View: | Kite Pharma, Inc. (KITE) | 01-Aug-17 | Market Option Sale (Planned) | 3,000 | $107.69 | $323,080.00 | (5%) 61.4K to 58.4K | (67%) |
03-Aug-17 9:14 PM View: | Kite Pharma, Inc. (KITE) | 01-Aug-17 | Market Sale (Planned) | 9,000 | $107.69 | $969,242.00 | (15%) 58.4K to 49.4K | (67%) |
27-Sep-17 9:42 PM View: | Kite Pharma, Inc. (KITE) | 15-Mar-17 | Market Sale | 7,511 | $83.31 | $625,741.00 | (15%) 49.4K to 41.89K | (116%) |
27-Dec-16 5:36 PM View: | Kite Pharma, Inc. (KITE) | 22-Dec-16 | Grant | 8,400 | -- | -- | 17% 50.0K to 58.4K | |
16-Mar-16 8:16 PM View: | Kite Pharma, Inc. (KITE) | 15-Mar-16 | Grant | 50,000 | -- | -- | 100% 0 to 50.0K |